Frank Mottola insider trades
Open-market stock purchases and sales by Frank Mottola, SVP, Chief Tech. Ops. Officer at Supernus Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 21, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $37.1K |
| Aug 12, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Jul 29, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 9, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold | $87.1K |
| Mar 6, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $98.1K |
| Mar 6, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 28, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $49.5K |
| Feb 25, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $31K |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $18.7K |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | $34.1K |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 24, 2026 | SUPN Supernus Pharmaceuticals, Inc | Sold (not open market) | — |
| Feb 18, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 18, 2026 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 19, 2025 | SUPN Supernus Pharmaceuticals, Inc | Sold | $251K |
| Dec 19, 2025 | SUPN Supernus Pharmaceuticals, Inc | Sold | $757K |
| Dec 19, 2025 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 19, 2025 | SUPN Supernus Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- SUPN Supernus Pharmaceuticals, Inc: 8 sales, last Aug 12, 2026